Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Identification of Sphingosine Kinases As Therapeutic Targets in B-Lineage Acute Lymphoblastic Leukemia

Craig T Wallington-Beddoe, BSc, MB BS, FRACP, FRCPA, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, Linda J Bendall, BSc, PhD

Blood (2012) 120 (21): 1499.

https://doi.org/10.1182/blood.V120.21.1499.1499

Published: 2012

Journal Articles

Effects of G-CSF On Acute Lymphoblastic Leukemia.

Jordan Basnett, BSc(Hons), Adam Cisterne, BSc(Hons), Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, Linda J Bendall, BSc, PhD

Blood (2012) 120 (21): 2564.

https://doi.org/10.1182/blood.V120.21.2564.2564

Published: 2012

Journal Articles

Upregulation of the Chemokine Receptor CCR5 on CD16+ Myeloid Blood Dendritic Cells in Allogeneic Hemopoietic Cell Transplant Patients Predicts for Acute Graft Versus Host Disease

Kifah Shahin, PhD, Mary M Sartor, BSc, MSc, Derek NJ Hart, MBCHB, DPhil, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA

Blood (2011) 118 (21): 1982.

https://doi.org/10.1182/blood.V118.21.1982.1982

Published: 2011

Journal Articles

Increased Production of the Inflammatory Cytokine IL12p70 by Activated Human Blood Dendritic Cells Is Associated with Increased Severity of Acute Graft Vs Host Disease Post Allogeneic Hemopoietic Cell Transplantation

Mary M Sartor, BSc, MSc, Jenny Lau, PhD, David Gottlieb, MB, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA

Blood (2011) 118 (21): 4539.

https://doi.org/10.1182/blood.V118.21.4539.4539

Published: 2011

Journal Articles

CCR5 Expression On Circulating Blood DC Post-Allogeneic Hemopoietic Cell Transplant Is Highly Predictive for the Development of Clinically Significant Acute Graft Versus Host Disease.

Mary M Sartor, BSc, MSc, Jenny Lau, BSc, hons, David J Gottlieb, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA

Blood (2009) 114 (22): 2251.

https://doi.org/10.1182/blood.V114.22.2251.2251

Published: 2009

Journal Articles

The JNK Pathway Is a Significant Determinant of Sensitivity to DNA Damaging Agents in Pre-B ALL.

Philip O. Saunders, MB, MRCP, FRACP, FRCPA, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, Linda J. Bendall, BSc, PhD

Blood (2009) 114 (22): 3786.

https://doi.org/10.1182/blood.V114.22.3786.3786

Published: 2009

Journal Articles

Combining RAD001 (Everolimus) with Proteasome Inhibitors Bortezomib (Velcade) or MG132 Significantly Enhances Pre-B ALL Cell Death in Vitro.

Philip O. Saunders, MB, MRCP, FRACP, FRCPA, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, Linda J. Bendall, BSc, PhD

Blood (2009) 114 (22): 2743.

https://doi.org/10.1182/blood.V114.22.2743.2743

Published: 2009

Journal Articles

A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML

Andrew W. Roberts, MBBS, PhD, Simon He, MBBS, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, Mark S Hertzberg, MBBS, FRACP, FRCP, PhD, Simon T S Durrant, MRCS, MBBS, MRCP, FRCP, David Ritchie, MBChB, FRACP, FRCPA, PhD, Ian D. Lewis, MBBS, PhD, FRACP, FRCPA, Paula Marlton, MBBS, FRACP, FRCPA, Andrew J McLachlan, PhD, Trina M Yeadon, PhD, Samantha J Busfield, PhD, Megan J Barnden, PhD, Roslyn Davis, BSc(Hons), Sarah Hosback, PhD, Danijela Mirosa, PhD, Mark Biondo, PhD, Simone Bamford, MBBS, FRACGP, Mark DeWitte, VMD, Russell Basser, MBBS, MD, FRACP

Blood (2008) 112 (11): 2956.

https://doi.org/10.1182/blood.V112.11.2956.2956

Published: 2008

Journal Articles

Best Approach for Harvesting Bone Marrow to Maximize TNC and CD34+ Cell Counts

Nalini K Pati, MBBS, MD, DNB, Frances Garvin, BSc, Vicki Antonenas, BSc, Ian Kerridge, FRACP, FRCPA, PhD, Kenneth F Bradstock, MB, PhD, FRACP, FRCPA, David J Gottlieb, MD, FRACP, FRCPA

Blood (2008) 112 (11): 3468.

https://doi.org/10.1182/blood.V112.11.3468.3468

Published: 2008

Journal Articles

Dose Escalated RAD001 (Everolimus) Enhances Chemosensitivity in Precursor-B Acute Lymphoblastic Leukemia, through a JNK Dependent Suppression of Cell Cycle Checkpoint Regulation.

Philip O. Saunders, MB, MRCP, FRACP, FRCPA, Kenneth F. Bradstock, MB, PhD, FRACP, FRCPA, Linda J. Bendall, BSc, PhD

Blood (2008) 112 (11): 1604.

https://doi.org/10.1182/blood.V112.11.1604.1604

Published: 2008

NARROW

Identification of Sphingosine Kinases As Therapeutic Targets in B-Lineage Acute Lymphoblastic Leukemia

Effects of G-CSF On Acute Lymphoblastic Leukemia.

Upregulation of the Chemokine Receptor CCR5 on CD16+ Myeloid Blood Dendritic Cells in Allogeneic Hemopoietic Cell Transplant Patients Predicts for Acute Graft Versus Host Disease

Increased Production of the Inflammatory Cytokine IL12p70 by Activated Human Blood Dendritic Cells Is Associated with Increased Severity of Acute Graft Vs Host Disease Post Allogeneic Hemopoietic Cell Transplantation

CCR5 Expression On Circulating Blood DC Post-Allogeneic Hemopoietic Cell Transplant Is Highly Predictive for the Development of Clinically Significant Acute Graft Versus Host Disease.

The JNK Pathway Is a Significant Determinant of Sensitivity to DNA Damaging Agents in Pre-B ALL.

Combining RAD001 (Everolimus) with Proteasome Inhibitors Bortezomib (Velcade) or MG132 Significantly Enhances Pre-B ALL Cell Death in Vitro.

A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML

Best Approach for Harvesting Bone Marrow to Maximize TNC and CD34+ Cell Counts

Dose Escalated RAD001 (Everolimus) Enhances Chemosensitivity in Precursor-B Acute Lymphoblastic Leukemia, through a JNK Dependent Suppression of Cell Cycle Checkpoint Regulation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only